全文获取类型
收费全文 | 15448篇 |
免费 | 1482篇 |
国内免费 | 1784篇 |
出版年
2024年 | 11篇 |
2023年 | 183篇 |
2022年 | 249篇 |
2021年 | 663篇 |
2020年 | 528篇 |
2019年 | 706篇 |
2018年 | 684篇 |
2017年 | 504篇 |
2016年 | 696篇 |
2015年 | 1029篇 |
2014年 | 1246篇 |
2013年 | 1222篇 |
2012年 | 1540篇 |
2011年 | 1454篇 |
2010年 | 908篇 |
2009年 | 810篇 |
2008年 | 1011篇 |
2007年 | 935篇 |
2006年 | 755篇 |
2005年 | 685篇 |
2004年 | 556篇 |
2003年 | 509篇 |
2002年 | 499篇 |
2001年 | 237篇 |
2000年 | 201篇 |
1999年 | 195篇 |
1998年 | 137篇 |
1997年 | 100篇 |
1996年 | 61篇 |
1995年 | 54篇 |
1994年 | 55篇 |
1993年 | 34篇 |
1992年 | 46篇 |
1991年 | 33篇 |
1990年 | 34篇 |
1989年 | 21篇 |
1988年 | 16篇 |
1987年 | 12篇 |
1986年 | 15篇 |
1985年 | 12篇 |
1984年 | 9篇 |
1983年 | 7篇 |
1982年 | 5篇 |
1979年 | 4篇 |
1975年 | 5篇 |
1974年 | 3篇 |
1970年 | 3篇 |
1966年 | 3篇 |
1965年 | 3篇 |
1964年 | 3篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Jae-Won Hyun Su-Hyun Kim In Hye Jeong Suk-Won Ahn So-Young Huh Min Su Park Young In Eom In Soo Joo Joong-Yang Cho Eun Bin Cho Ju-Hong Min Byoung Joon Kim Nam-Hee Kim Jeeyoung Oh Kee Duk Park Ho Jin Kim 《PloS one》2015,10(5)
Objectives
Early identification of suboptimal responders to multiple sclerosis (MS) treatment is critical for optimizing therapeutic decisions. The Rio score (RS) and modified Rio score (MRS) were developed to discriminate the responses to interferon-beta (IFNB) treatment in MS patients. This study was performed to evaluate the utility of RS and MRS in daily clinical practice in Korea.Methods
This was a real-world setting, multicenter, retrospective study of MS patients treated with IFNB from 10 hospitals in Korea. We investigated whether the RS and MRS at the early stage of IFNB therapy could predict treatment responses over 3 years. Suboptimal treatment responses at 3 years were defined as the presence of clinical relapse and/or EDSS progression and/or patients who had been treated with INFB for at least for 1 year and therapy was switched due to perceived treatment failure during the 2 years of follow-up.Results
Seventy patients (50 females and 20 males) were enrolled; 92% (12/13) of patients with high RS and 86% (12/14) of patients with high MRS (score 2 or 3) were suboptimal responders, whereas 93% (53/57) of patients with low RS and 93% (52/56) patients with low MRS (score 0 or 1) showed optimal responses. New active lesions on MRI with clinical relapse in high RS and MRS were the most common combination in suboptimal responders.Conclusions
We confirmed that RS and MRS at 6–15 months of IFNB therapy were useful for predicting poor responders over 3 years. 相似文献992.
Geon Ha Kim Seun Jeon Kiho Im Hunki Kwon Byung Hwa Lee Ga Young Kim Hana Jeong Noh Eul Han Sang Won Seo Hanna Cho Young Noh Sang Eon Park Hojeong Kim Jung Won Hwang Cindy W. Yoon Hee Jin Kim Byoung Seok Ye Ju Hee Chin Jung-Hyun Kim Mee Kyung Suh Jong Min Lee Sung Tae Kim Mun-Taek Choi Mun Sang Kim Kenneth M Heilman Jee Hyang Jeong Duk L. Na 《PloS one》2015,10(4)
The purpose of this study was to investigate if multi-domain cognitive training, especially robot-assisted training, alters cortical thickness in the brains of elderly participants. A controlled trial was conducted with 85 volunteers without cognitive impairment who were 60 years old or older. Participants were first randomized into two groups. One group consisted of 48 participants who would receive cognitive training and 37 who would not receive training. The cognitive training group was randomly divided into two groups, 24 who received traditional cognitive training and 24 who received robot-assisted cognitive training. The training for both groups consisted of daily 90-min-session, five days a week for a total of 12 weeks. The primary outcome was the changes in cortical thickness. When compared to the control group, both groups who underwent cognitive training demonstrated attenuation of age related cortical thinning in the frontotemporal association cortices. When the robot and the traditional interventions were directly compared, the robot group showed less cortical thinning in the anterior cingulate cortices. Our results suggest that cognitive training can mitigate age-associated structural brain changes in the elderly.
Trial Registration
ClnicalTrials.gov NCT01596205 相似文献993.
994.
Jaewon Shim Hee Jin Son Yiseul Kim Ki Hwa Kim Jung Tae Kim Hana Moon Min Jung Kim Takumi Misaka Mee-Ra Rhyu 《PloS one》2015,10(4)
Although the five basic taste qualities—sweet, sour, bitter, salty and umami—can be recognized by the respective gustatory system, interactions between these taste qualities are often experienced when food is consumed. Specifically, the umami taste has been investigated in terms of whether it enhances or reduces the other taste modalities. These studies, however, are based on individual perception and not on a molecular level. In this study we investigated umami-sweet taste interactions using umami compounds including monosodium glutamate (MSG), 5’-mononucleotides and glutamyl-dipeptides, glutamate-glutamate (Glu-Glu) and glutamate-aspartic acid (Glu-Asp), in human sweet taste receptor hT1R2/hT1R3-expressing cells. The sensitivity of sucrose to hT1R2/hT1R3 was significantly attenuated by MSG and umami active peptides but not by umami active nucleotides. Inhibition of sweet receptor activation by MSG and glutamyl peptides is obvious when sweet receptors are activated by sweeteners that target the extracellular domain (ECD) of T1R2, such as sucrose and acesulfame K, but not by cyclamate, which interact with the T1R3 transmembrane domain (TMD). Application of umami compounds with lactisole, inhibitory drugs that target T1R3, exerted a more severe inhibitory effect. The inhibition was also observed with F778A sweet receptor mutant, which have the defect in function of T1R3 TMD. These results suggest that umami peptides affect sweet taste receptors and this interaction prevents sweet receptor agonists from binding to the T1R2 ECD in an allosteric manner, not to the T1R3. This is the first report to define the interaction between umami and sweet taste receptors. 相似文献
995.
996.
997.
Yat Ming Lau Tak Hong Cheung Winnie Yeo Frankie Mo Mei Yung Yu Kun Min Lee Wendy C. S. Ho Apple C. M. Yeung Priscilla T. Y. Law Paul K. S. Chan 《PloS one》2015,10(4)
High-risk human papillomavirus (HPV) types are associated with cervical cancer. It is well established that individual HPV types vary in oncogenicity, but current data on their prognostic implication remain controversial. We examined the association between HPV types/species and the survival of 236 Chinese women aged 26–87 (mean 54.4) years after receiving primary treatment for cervical cancer. Overall, 45.8% were of FIGO stage I, 41.9% stage II, and 12.3% stage III. The four most prevalent types found were HPV-16 (60.2%), HPV-18 (21.6%), HPV-52 (11.9%), and HPV-58 (9.3%). Overall, 19.5% of patients had multiple-type infections, 78.4% harboured one or more alpha-9 species, and 28.8% harboured one or more alpha-7 species. After a median follow-up of 8.0 years, 156 (66.1%) patients survived. The 3-year overall survival rate was 75.5%. Factors independently associated with a poorer 3-year overall survival were age >60 years, tumour size >4 cm, lymph node involvement and treatment with radiotherapy+/-chemotherapy. Univariate analysis showed HPV-16 single-type infection was associated with a marginally poorer disease-specific survival (71.6% vs. 87.0%, HR: 1.71, 95% CI = 1.01–2.90), whereas non-HPV-16 alpha-9 species was associated with a better disease-specific survival (90.0% vs. 76.2%, HR: 0.36, 95% CI = 0.16–0.79). However, on multivariate analysis, HPV infection status irrespective of different grouping methods, including individual types, species, single-type or co-infection, did not carry any significant prognostic significance. In conclusion, we did not observe any association between infection with a particular HPV type/species and survival. An HPV type-based stratification in treatment and follow-up plan could not be recommended. 相似文献
998.
Nami Kim Hong Min Kim Eun Soo Lee Jung Ok Lee Hye Jeong Lee Soo Kyung Lee Ji Wook Moon Ji Hae Kim Joong Kwan Kim Su Jin Kim Sun Hwa Park Choon Hee Chung Hyeon Soo Kim 《PloS one》2015,10(3)
Dibenzoylmethane (DBM) has been shown to exert a variety of beneficial effects on human health. However, the mechanism of action is poorly understood. In this study, DBM increased phosphorylation of AMP-activated protein kinase (AMPK) and stimulated glucose uptake in a skeletal muscle cell line. Both knockdown of AMPK with siRNA and inhibition with AMPK inhibitor blocked DBM-induced glucose uptake. DBM increased the concentration of intracellular calcium and glucose uptake due to DBM was abolished by STO-609 (a calcium/calmodulin-dependent protein kinase inhibitor). DBM stimulated phosphorylation of p38 mitogen-activated protein kinase (p38 MAPK), which was blocked by pretreatment with compound C, an AMPK inhibitor. The expression of glucose transporter type 4 (GLUT4) was increased by DBM. The translocation of GLUT4 to the plasma membrane was also increased by DBM in AMPK dependently. In addition, DBM suppressed weight gain and prevented fat accumulation in the liver and abdomen in mice fed a high-fat diet. In pre-adipocyte cells, DBM decreased the activity of acetyl-CoA carboxylase (ACC), the rate-limiting enzyme of fatty acid synthesis. Expression of the adipogenic gene, fatty acid synthase (FAS), was suppressed by DBM in an AMPK-dependent manner. These results showed that the beneficial metabolic effects of DBM might be due to regulation of glucose uptake via AMPK in skeletal muscle and inhibition of adipogenesis in pre-adipocytes. 相似文献
999.
Jong Hyuk Lee Chang Min Park Sang Joon Park Jae Seok Bae Sang Min Lee Jin Mo Goo 《PloS one》2015,10(5)
ObjectivesTo retrospectively investigate the added value of quantitative 3D shape analysis in differentiating encapsulated from invasive thymomas.ResultsSignificant differences were observed between encapsulated and invasive thymomas, in terms of cystic changes (p=0.004), sphericity (p=0.016), and discrete compactness (p=0.001). Subsequent binary logistic regression analysis revealed that absence of cystic change (adjusted odds ratio (OR) = 6.636; p=0.015) and higher discrete compactness (OR = 77.775; p=0.012) were significant differentiators of encapsulated from invasive thymomas. ROC analyses revealed that the addition of 3D shape analysis to clinical and CT features (AUC, 0.955; 95% CI, 0.935–0.975) provided significantly higher performance in differentiating encapsulated from invasive thymomas than clinical and CT features (AUC, 0.666; 95% CI, 0.626–0.707) (p<0.001).ConclusionAddition of 3D shape analysis, particularly discrete compactness, can improve differentiation of encapsulated thymomas from invasive thymomas. 相似文献
1000.
Eun Kyung Jang Won Gu Kim Ho-Cheol Kim Jin-Won Huh Hyemi Kwon Yun Mi Choi Min Ji Jeon Tae Yong Kim Young Kee Shong Jin-Sook Ryu Won Bae Kim 《PloS one》2015,10(4)
ObjectivePulmonary function test (PFT) is a useful tool for an objective assessment of respiratory function. Impaired pulmonary function is critical for the survival and quality of life in patients with pulmonary metastases of solid cancers including thyroid cancer. This study aimed to evaluate clinical factors associated with severely impaired pulmonary function by serial assessment with PFT in patients with pulmonary metastasis of differentiated thyroid cancer (DTC) who received radioactive iodine treatment (RAIT).PatientsThis retrospective study enrolled 31 patients who underwent serial PFTs before and after RAIT for pulmonary metastasis of DTC. We evaluated the risk factors for severe impairment of pulmonary function.ResultsThe median age of the patients was 44.1 years and 18 of them were female patients. Severe impairment of pulmonary function was observed in five patients (16%) after a median of three RAITs (cumulative I-131 activity = 20.4 GBq). These patients were older and more frequently had mild impairment of baseline pulmonary function, respiratory symptoms, or progressive disease compared with patients with stable pulmonary function. Neither cumulative dose nor number of RAIT was associated with decreased pulmonary function. Coexisting pulmonary diseases, presence of respiratory symptoms, and metastatic disease progression were significantly associated with severe decrease in forced vital capacity during follow-up (p =.047, p =.011, and p =.021, respectively).ConclusionsPulmonary function was severely impaired during follow-up in some patients with pulmonary metastasis of DTC after a high-dose RAITs. Neither the number of RAIT nor the cumulative I-131 activity was associated with decreased pulmonary function. Serial PFT might be considered for some high-risk patients during follow-up. 相似文献